Literature DB >> 12525291

Babesiosis: An Update on Epidemiology and Treatment.

Jeffrey A. Gelfand1, Michael V. Callahan.   

Abstract

Babesiosis is caused by a tick-borne hemoparasite that, like malaria, can cause fever, hemolysis, and anemia. Typically self-limited, in the asplenic, immunocompromised, or elderly, disease can be severe or deadly. US cases have been primarily due to Babesia microti; WA-1, which may be related to Babesia gibsoni; and MO-1, related to Babesia divergens. European infections are usually due to B. divergens. North American cases are treated either with quinine and clindamycin or with atovaquone and azithromycin. The latter regimen appears less toxic.

Entities:  

Year:  2003        PMID: 12525291     DOI: 10.1007/s11908-003-0065-z

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  38 in total

Review 1.  Coinfecting deer-associated zoonoses: Lyme disease, babesiosis, and ehrlichiosis.

Authors:  C Thompson; A Spielman; P J Krause
Journal:  Clin Infect Dis       Date:  2001-08-06       Impact factor: 9.079

2.  Transfusion-transmitted babesiosis: a case report from a new endemic area.

Authors:  E D Mintz; J F Anderson; R G Cable; J L Hadler
Journal:  Transfusion       Date:  1991-05       Impact factor: 3.157

3.  Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle.

Authors:  S R Telford; J E Dawson; P Katavolos; C K Warner; C P Kolbert; D H Persing
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 4.  Tick-borne diseases in the United States.

Authors:  D H Spach; W C Liles; G L Campbell; R E Quick; D E Anderson; T R Fritsche
Journal:  N Engl J Med       Date:  1993-09-23       Impact factor: 91.245

5.  Human babesial infections in Europe.

Authors:  P Brasseur; A Gorenflot
Journal:  Rocz Akad Med Bialymst       Date:  1996

6.  Babesiosis in Washington State: a new species of Babesia?

Authors:  R E Quick; B L Herwaldt; J W Thomford; M E Garnett; M L Eberhard; M Wilson; D H Spach; J W Dickerson; S R Telford; K R Steingart; R Pollock; D H Persing; J M Kobayashi; D D Juranek; P A Conrad
Journal:  Ann Intern Med       Date:  1993-08-15       Impact factor: 25.391

7.  Treatment of babesiosis by red blood cell exchange in an HIV-positive, splenectomized patient.

Authors:  L Machtinger; S R Telford; C Inducil; E Klapper; S H Pepkowitz; D Goldfinger
Journal:  J Clin Apher       Date:  1993       Impact factor: 2.821

8.  Infection with a babesia-like organism in northern California.

Authors:  D H Persing; B L Herwaldt; C Glaser; R S Lane; J W Thomford; D Mathiesen; P J Krause; D F Phillip; P A Conrad
Journal:  N Engl J Med       Date:  1995-02-02       Impact factor: 91.245

9.  Babesiosis in Wisconsin: a potentially fatal disease.

Authors:  B L Herwaldt; F E Springs; P P Roberts; M L Eberhard; K Case; D H Persing; W A Agger
Journal:  Am J Trop Med Hyg       Date:  1995-08       Impact factor: 2.345

Review 10.  Acute respiratory failure in patients treated for babesiosis.

Authors:  M R Boustani; T J Lepore; J A Gelfand; D S Lazarus
Journal:  Am J Respir Crit Care Med       Date:  1994-06       Impact factor: 21.405

View more
  3 in total

1.  Establishment of a continuous in vitro culture of Babesia duncani in human erythrocytes reveals unusually high tolerance to recommended therapies.

Authors:  Amanah Abraham; Ioana Brasov; Jose Thekkiniath; Nicole Kilian; Lauren Lawres; Ruiyi Gao; Kai DeBus; Lan He; Xue Yu; Guan Zhu; Morven M Graham; Xinran Liu; Robert Molestina; Choukri Ben Mamoun
Journal:  J Biol Chem       Date:  2018-11-21       Impact factor: 5.157

Review 2.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 3.  Zoonotic Babesia: A scoping review of the global evidence.

Authors:  Kaitlin M Young; Tricia Corrin; Barbara Wilhelm; Carl Uhland; Judy Greig; Mariola Mascarenhas; Lisa A Waddell
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.